Doctor profile · Federal record

Dr. Michael Carlson, MD

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Nashville, TN

  • NPI 1386639219
  • Accepts Medicare
  • 41 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
330 23Rd Ave N, Suite 500
Nashville, TN 372031534
(615) 342-5900
fax (615) 342-7864

Credentials & registration

NPPES · NUCC
NPI registered
September 2005 — 21 yrs on file
Profile last updated
June 11, 2015
Year of graduation
1985 — 41 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Tennessee #MD019713
Medicaid (2)
KY #64915648 · TN #3060045

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1386639219. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
5,361
Distinct HCPCS
9
Medicare allowed
$178,737
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 4,620 45 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 216 154 $120
99215 Established patient office or other outpatient visit, 40-54 minutes 159 121 $167
96372 Injection of drug or substance under skin or into muscle 122 48 $13
82962 Blood glucose (sugar) test performed by hand-held instrument 101 75 $3
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 54 42 $33
99204 New patient office or other outpatient visit, 45-59 minutes 41 41 $156
99205 New patient office or other outpatient visit, 60-74 minutes 36 36 $207
76536 Ultrasound scan of head and neck soft tissue 12 11 $103

In context: peer comparison

Among 16 peers in this city , average services per provider: 277. This provider delivers 19× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$12,933
Transactions
158
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novo Nordisk Inc 31 $6,862.94
Corcept Therapeutics 8 $2,253.53
Amgen Inc. 24 $1,111.27
Lilly USA, LLC 19 $444.53
BETA BIONICS, INC. 13 $415.48
Abbott Laboratories 14 $277.51
SANOFI-AVENTIS U.S. LLC 11 $203.48
Xeris Pharmaceuticals, Inc. 10 $203.41
CeQur Corporation 1 $174.82
Boehringer Ingelheim Pharmaceuticals, Inc. 8 $134.60
Insulet Corporation 6 $127.35
Tandem Diabetes Care, Inc. 4 $100.93
Alexion Pharmaceuticals, Inc. 4 $78.35
IBSA Pharma Inc. 2 $60.24
Verity Pharmaceuticals Inc. 3 $52.62

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$8,839
Food and Beverage
$4,094

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,208
Patients
317
Total drug cost
$679,309
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 221 70 $3,995
Ozempic (Semaglutide) Brand 137 27 $203,553
Synthroid (Levothyroxine Sodium) Brand 118 32 $15,466
Metformin Hcl Er (Metformin Hcl) Brand 106 33 $2,507
Trulicity (Dulaglutide) Brand 99 14 $119,461
Jardiance (Empagliflozin) Brand 97 21 $138,517
Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) Brand 67 20 $8,656
Methimazole Generic 62 16 $651
Cinacalcet Hcl Generic 58 14 $10,703
Farxiga (Dapagliflozin Propanediol) Brand 47 13 $61,885

Frequently asked questions

Auto-generated from federal data
What is Dr. Michael Carlson's medical specialty?
Dr. Michael Carlson practices Endocrinology, Diabetes & Metabolism Physician in Nashville, TN.
Where does Dr. Michael Carlson practice?
Dr. Michael Carlson practices at 330 23Rd Ave N, Nashville, TN 372031534. Office phone: 6153425900.
What is Dr. Michael Carlson's NPI?
Dr. Michael Carlson's National Provider Identifier (NPI) is 1386639219, issued by NPPES.
Does Dr. Michael Carlson accept Medicare assignment?
Yes. Dr. Michael Carlson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Carlson commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.